135 related articles for article (PubMed ID: 30993482)
1. Feasibility of initial treatment in elderly patients with ovarian cancer in Japan: a retrospective study.
Bun S; Yunokawa M; Ebata T; Kobayashi Kato M; Shimoi T; Kato T; Tamura K
Int J Clin Oncol; 2019 Sep; 24(9):1111-1118. PubMed ID: 30993482
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer.
Bun S; Yunokawa M; Ebata T; Shimomura A; Shimoi T; Kodaira M; Yonemori K; Shimizu C; Fujiwara Y; Kato T; Makino Y; Hayashi Y; Tamura K
Cancer Chemother Pharmacol; 2016 Oct; 78(4):745-52. PubMed ID: 27522647
[TBL] [Abstract][Full Text] [Related]
3. Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study.
Pignata S; Ferrandina G; Scarfone G; Scollo P; Odicino F; Cormio G; Katsaros D; Frigerio L; Mereu L; Ghezzi F; Manzione L; Lauria R; Breda E; Alletti DG; Ballardini M; Vernaglia A; Sorio R; Tumolo S; Musso P; Magni G; Pisano C; Morabito A
Crit Rev Oncol Hematol; 2009 Sep; 71(3):233-41. PubMed ID: 19179095
[TBL] [Abstract][Full Text] [Related]
4. Performance status rather than age is the key prognostic factor in second-line treatment of elderly patients with epithelial ovarian carcinoma.
Gronlund B; Høgdall C; Hansen HH; Engelholm SA
Cancer; 2002 Apr; 94(7):1961-7. PubMed ID: 11932898
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients.
Susini T; Amunni G; Busi E; Villanucci A; Carriero C; Taddei G; Marchionni M; Scarselli G
Int J Gynecol Cancer; 2007; 17(3):581-8. PubMed ID: 17309560
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors.
Shibata K; Kikkawa F; Mika M; Suzuki Y; Kajiyama H; Ino K; Mizutani S
Int J Gynecol Cancer; 2003; 13(5):587-92. PubMed ID: 14675340
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (≥70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian Cancer in the International ROSiA Study.
Selle F; Colombo N; Korach J; Mendiola C; Cardona A; Ghazi Y; Oza AM
Int J Gynecol Cancer; 2018 May; 28(4):729-737. PubMed ID: 29498983
[TBL] [Abstract][Full Text] [Related]
9. Real-world data on initial treatment strategies for older adult patients with endometrial cancer in Japan.
Yunokawa M; Sasada S; Takehara Y; Takahashi K; Shimoi T; Yonemori K; Ishikawa M; Kato T; Tamura K
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1051-1058. PubMed ID: 31482227
[TBL] [Abstract][Full Text] [Related]
10. Treatment of advanced ovarian carcinoma in the elderly.
Marchetti DL; Lele SB; Priore RL; McPhee ME; Hreshchyshyn MM
Gynecol Oncol; 1993 Apr; 49(1):86-91. PubMed ID: 8482566
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study.
Sabatier R; Calderon B; Lambaudie E; Chereau E; Provansal M; Cappiello MA; Viens P; Rousseau F
Int J Gynecol Cancer; 2015 Jun; 25(5):815-22. PubMed ID: 25768081
[TBL] [Abstract][Full Text] [Related]
12. Age-related differences in prognosis and prognostic factors among patients with epithelial ovarian cancer.
Yoshikawa K; Fukuda T; Uemura R; Matsubara H; Wada T; Kawanishi M; Tasaka R; Kasai M; Hashiguchi Y; Ichimura T; Yasui T; Sumi T
Mol Clin Oncol; 2018 Sep; 9(3):329-334. PubMed ID: 30112179
[TBL] [Abstract][Full Text] [Related]
13. Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center.
Lee YJ; Chung YS; Lee JY; Nam EJ; Kim SW; Kim S; Kim YT
J Gynecol Oncol; 2018 Jul; 29(4):e63. PubMed ID: 29770632
[TBL] [Abstract][Full Text] [Related]
14. A study of treatments and outcomes in elderly women with cervical cancer.
Shimamoto K; Saito T; Kitade S; Tomita Y; Nagayama R; Yamaguchi S; Ariyoshi K; Okadome M
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():174-179. PubMed ID: 29960201
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study.
Ansquer Y; Leblanc E; Clough K; Morice P; Dauplat J; Mathevet P; Lhommé C; Scherer C; Tigaud JD; Benchaib M; Fourme E; Castaigne D; Querleu D; Dargent D
Cancer; 2001 Jun; 91(12):2329-34. PubMed ID: 11413522
[TBL] [Abstract][Full Text] [Related]
16. Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancer.
Bruchim I; Altaras M; Fishman A
Gynecol Oncol; 2002 Sep; 86(3):274-8. PubMed ID: 12217748
[TBL] [Abstract][Full Text] [Related]
17. Early treatment modifications improve chemotherapy adherence in ovarian cancer patients ≥70 years.
Heilmann T; Pfisterer J; Hempel AM; Saß S; Hedderich J; Pujade-Lauraine E; Harter P; du Bois A; Hilpert F
Gynecol Oncol; 2019 Jun; 153(3):616-624. PubMed ID: 30905433
[TBL] [Abstract][Full Text] [Related]
18. A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.
Morimoto A; Nagao S; Kogiku A; Yamamoto K; Miwa M; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Fujiwara K
Jpn J Clin Oncol; 2016 Jun; 46(6):517-21. PubMed ID: 26977055
[TBL] [Abstract][Full Text] [Related]
19. Primary chemotherapy patterns for ovarian cancer treatment in Japan.
Shirai T; Imanaka Y; Sekimoto M; Ishizaki T;
J Obstet Gynaecol Res; 2009 Oct; 35(5):926-34. PubMed ID: 20149043
[TBL] [Abstract][Full Text] [Related]
20. Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC-IV ovarian cancer. Critical analysis in elderly patients.
Cascales-Campos P; Gil J; Gil E; Feliciangeli E; López V; Gonzalez AG; Ruiz-Pardo J; Nieto A; Parrilla P
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():88-93. PubMed ID: 24965986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
